C-type natriuretic peptide inhibits constrictive remodeling without compromising re-endothelialization in balloon-dilated renal arteries

Journal of Endovascular Therapy

Volumn 12, Issue 2, 2005, Pages 171-182

  Kühnl, Andreas ^a   Pelisek, Jaroslav ^a   Tian, Wen ^a   Kuhlmann, Michael ^a   Rolland, Pierre H ^b   Mekkaoui, Choukri ^b   Fuchs, Alexandra ^c   Nikol, Sigrid ^a,d  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b Université de Marseille   (France)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Angioplasty; Gene therapy; Natriuretic peptide; Re endothelialization; Remodeling; Renal artery; Restenosis

Indexed keywords

BETA GALACTOSIDASE; BLOOD CLOTTING FACTOR 8; CD31 ANTIGEN; EVANS BLUE; KI 67 ANTIGEN; LIPOSOME; NATRIURETIC PEPTIDE TYPE C; VON WILLEBRAND FACTOR;

ANGIOGRAPHY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY DIAMETER; ARTICLE; BALLOON DILATATION; CELL PROLIFERATION; CNP GENE; CONTROLLED STUDY; GENE; GENE TRANSFER; HISTOLOGY; IMMUNOHISTOCHEMISTRY; KIDNEY ARTERY STENOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RENAL ARTERY; RESTENOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SWINE;

EID: 17144367288     PISSN: 15266028     EISSN: None     Source Type: Journal    
DOI: 10.1583/1384R.1     Document Type: Article

References (33)

1. Shammas NW, Kapalis MJ, Dippel EJ, et al. Clinical and angiographic predictors of restenosis following renal artery stenting. J Invasive Cardiol. 2004;16:10-13.
2. Vashist A, Heller EN, Brown EJ, et al. Renal artery stenosis: a cardiovascular perspective. Am Heart J. 2002;143:559-564.
3. Pompa JJ, Topol EJ. Factors influencing restenosis after coronary angioplasty. Am J Med. 1990;88:16N-24N.
4. Andersen HR, Maeng M, Thorwest M, et al. Remodeling rather than neointimal formation explains luminal narrowing after deep vessel wall injury: insights from a porcine coronary (re)stenosis model. Circulation. 1996;93:1716-1724.
5. Currier JW, Faxon DP. Restenosis after percutaneous transluminal coronary angioplasty; have we been aiming at the wrong target? J Am Coll Cardiol. 1995;25:516-520.
6. Lafont A, Guzman LA, Whitlow PL, et al. Restenosis after experimental angioplasty. Intimal, medial and adventitial changes associated with constrictive remodeling. Circ Res. 1995;76:996-1002.
7. Post MJ, Borst C, Kuntz RE. The relative importance of arterial remodeling compared with intimal hyperplasia in lumen renarrowing after balloon angioplasty. A study in the normal rabbit and the hypercholesterolemic Yucatan micropig. Circulation. 1994;89:2816-2821.
8. Strauss BH, Chisholm RJ, Keeley FW, et al. Extracellular matrix remodeling after balloon angioplasty injury in a rabbit model of restenosis. Circ Res. 1994;75:650-658.
9. Murphy BE. Drug-eluting stems: some first-generation problems. Am Heart Hosp J. 2004;2:80-84.
10. Pelisek J, Kuehnl A, Fuchs A, et al. Functional analysis of genomic DNA, cDNA and nucleotide sequence of the mature C-type natriuretic peptide gene in vascular cells. Arterioscler Thromb Vasc Biol. 2004;24:1646-1651.
11. Armeanu S, Pelisek J, Krausz E, et al. Optimization of nonviral gene transfer of vascular smooth muscle cells in vitro and in vivo. Mol Ther. 2000;1:366-375.
12. Pelisek J, Engelmann MG, Golda A, et al. Optimization of nonviral transfection: variables influencing liposome-mediated gene transfer in proliferating vs. quiescent cells in culture and in vivo using a porcine restenosis model. J Mol Med. 2002;80:724-736.
13. Nikol S, Huehns TY, Krausz E, et al. Needle injection catheter delivery of the gene for an antibacterial agent inhibits neointimal formation. Gene Ther. 1999;6:737-748.
14. Nikol S, Pelisek J, Engelmann MG, et al. Prevention of restenosis using the gene for Cecropin complexed with DOCSPER liposomes under optimized conditions. Int J Angiol. 2000;9:87-94.
15. Groth D, Keil O, Lehmana C, et al. Preparation and characterization of a new lipospermine for gene delivery into various cells. Int J Pharmacol. 1998;162:143-157.
16. Nikol S, Engelmann MG, Pelisek J, et al. Local perivascular application of low amounts of a plasmid encoding for vascular endothelial growth factor (VEGF165) is efficient for therapeutic angiogenesis in pigs. Acta Physiol Scand. 2002;176:151-159.
17. Gonschior P, Pahl C, Huehns TY, et al. Comparison of local intravascular drug-delivery catheter systems. Am Heart J. 1995;130:1174-1181.
18. Gonschior P, Goetz AE, Huehns TY, et al. A new catheter for prolonged local drug application. Coron Artery Dis. 1995;6:329-334.
19. Asahara T, Chen D, Tsurumi Y, et al. Accelerated restitution of endothelial integrity and endothelium-dependent function after ph-VEGF165 gene transfer. Circulation. 1996;94:3291-3302.
20. Morishige K, Shimokawa H, Yamawaki T, et al. Local adenovirus-mediated transfer of C-type natriuretic peptide suppresses vascular remodeling in porcine coronary arteries in vivo. J Am Coll Cardiol. 2000;35:1040-1047.
21. Schluter C, Duchrow M, Wohlenberg C. The cell proliferation-associated antigen of antibody Ki-67: a very large, ubiquitous nuclear protein with numerous repeated elements, representing a new kind of cell cycle-maintaining proteins. J Cell Biol. 1993;123:513-522.
22. Jones TR, Kao KJ, Pizzo SV, et al. Endothelial cell surface expression and binding of factor VIII/von Willebrand factor. Am J Pathol. 1981;103:304-308.
23. Newman PJ, Berndt MC, Gorski J. PECAM-1 (CD31) cloning and relation to adhesion molecules of the immunoglobulin gene superfamily. Science. 1990;247:1219-1222.
24. Shimizu M, Pelisek J, Nikol S. Vasculogenesis and angiogenesis depend on the developmental origin in the arterial tree. Curr Med Chem. 2002;9:1241-1253.
25. Beebe H, Chesebro K, Merchant F, et al. Results of renal artery balloon angioplasty limit its indications. J Vasc Surg. 1988;8:300-306.
26. Engelmann MG, Shimizu M, Pelisek J, et al. Comparison of surgical versus endovascular occlusion models in pig femoral arteries. J Endovasc Ther. 2004;11:71-79.
27. Doi K, Itoh H, Ikeda T, et al. Adenovirus-mediated gene transfer of C-type natriuretic peptide causes G1 growth inhibition of cultured vascular smooth muscle cells. Biochem Biophys Res Commun. 1997;239:889-894.
28. Furuya M, Miyazaki T, Honbou N, et al. C-type natriuretic peptide inhibits intimal thickening after vascular injury. Ann NY Acad Sci. 1995;748:517-523.
29. Yasuda S, Kanna M, Sakuragi S, et al. Local delivery of single low-dose of C-type natriuretic peptide, an endogenous vascular modulator, inhibits neointimal hyperplasia in a balloon-injured rabbit iliac artery model. J Cardiovasc Pharmacol. 2002;39:784-788.
30. Furuya M, Aisaka K, Miyazaki T, et al. C-type natriuretic peptide inhibits intimal thickening after vascular injury. Biochem Biophys Res Commun. 1993;193:248-253.
31. Ikeda M, Kohno M, Yasunari K, et al. Natriuretic peptide family as a novel antimigration factor of vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 1997;17:731-736.
32. Ohno N, Itoh H, Ikeda T, et al. Accelerated reendothelialization with suppressed thrombogenic property and neointimal hyperplasia of rabbit jugular vein grafts by adenovirus-mediated gene transfer of C-type natriuretic peptide. Circulation. 2002;105:1623-1626.
33. Huehns TY, Krausz E, Mrochen S, et al. Neointimal growth can be influenced by local adventitial gene manipulation via a needle injection catheter. Atherosclerosis. 1999;144:135-150.